3651 results for «279»
3651 results
Fighting intracardiac masses
21 May 2026 – From EuroPCR 2026
This session focuses on the percutaneous management of intracardiac masses, presenting innovative approaches such as angiovac-assisted vegetation removal, management of mechanical mitral valve complications, and treatment options for right ventricular tumors. It also evaluates the emerging role of percutaneous therapies in infective endocarditis involving TAVI valves...
New frontiers in coronary disease treatment
21 May 2026 – From EuroPCR 2026
Examine recent advances in coronary disease treatment focusing on drug-eluting stents versus drug-coated balloon strategies. This session presents real-world data on lesion preparation, sex-specific outcomes, physiological disease patterns, and procedural factors influencing PCI success.
Management of uncommon TAVI complications
21 May 2026 – From EuroPCR 2026
This session delves into the management of uncommon but critical complications arising from Transcatheter Aortic Valve Implantation (TAVI). Through detailed case studies from Italy, Lebanon, and Turkey, it highlights real-time decision-making strategies for life-threatening scenarios including left ventricular outflow tract obstruction, acute aortic dissection, and complex...
Refining the gold standard: what is new in DES
21 May 2026 – From EuroPCR 2026
This session explores recent advancements in drug-eluting stent (DES) technology, featuring global real-world evidence on short dual antiplatelet therapy (DAPT) with polymer-free DES, angiographic outcomes from pooled TARGET trials, and real-world registry data on various DES platforms. It also presents post-marketing surveillance results and systematic reviews...
NSTEMI: when everything does not go as planned
21 May 2026 – From EuroPCR 2026
This session presents complex cases of NSTEMI where unexpected challenges arise during intervention. It provides a comprehensive review of complication management strategies, including coronary perforation techniques. Through detailed case analyses from diverse centers, attendees gain practical insights into troubleshooting and treatment adaptations essential for managing difficult...
Publishing in interventional cardiology: aligning authors, editors and impact
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on publishing in interventional cardiology by aligning the expectations of authors, editors, reviewers, and readers. It addresses differences in paper interpretation, common misalignments between scientific intent and editorial outcomes, and strategies to enhance clarity, relevance, and impact of scientific publications.
Precision TAVI - Seering marginal gains
21 May 2026 – From EuroPCR 2026
This session delves into precision techniques in transcatheter aortic valve implantation (TAVI), highlighting novel stepwise implantation methods for self-expanding valves, the effects of internal diameter and valve fracture on gradients post valve-in-valve TAVI, and comparative analyses of implantation-depth variability across large-size TAVI platforms. Additionally, it evaluates...
TAVI procedural complications - Part 8: aortic dissection, multiple valves procedures, and more
21 May 2026 – From EuroPCR 2026
This session addresses complex procedural complications encountered during TAVI, featuring challenging cases such as aortic dissection, multiple valve procedures including redo TAVI in patients with left ventricular assist devices, and structural failures like valve infolding and embolisation. It emphasizes strategic decision-making under critical circumstances to optimize...
New insights into pharmacological treatment for STEMI
21 May 2026 – From EuroPCR 2026
This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...
Risk and prognosis predictors in STEMI
21 May 2026 – From EuroPCR 2026
This session explores key risk and prognostic factors in ST-elevation myocardial infarction (STEMI), encompassing biomarker-based outcome prediction, the influence of low-density lipoprotein cholesterol on myocardial injury, and thrombotic risk in atrial fibrillation patients undergoing PCI. It further examines gender differences in young STEMI patients, the safety...
Complication management during STEMI intervention: Czech Republic - Greece and Iraq present their cases
21 May 2026 – From EuroPCR 2026
This session presents a critical analysis of procedural strategies in primary PCI for STEMI by exploring complex cases from the Czech Republic, Greece, and Iraq. It delves into mechanisms and management of major PCI complications and highlights the role of emerging novel technologies in primary PCI...
TAVI procedural complications - Part 9: coronary occlusion, difficult aortic valve crossing and more
21 May 2026 – From EuroPCR 2026
Explore the management of complex TAVI procedural complications, including coronary occlusion and difficult valve crossing. This session presents innovative bailout techniques, diagnostic challenges, and case-based discussions highlighting acute coronary syndrome post-TAVI and nuanced approaches to valve-in-valve interventions.
Post myocardial infarction and iatrogenic VSDs: case-based decision taking
21 May 2026 – From EuroPCR 2026
This session focuses on decision-making in post-myocardial infarction and iatrogenic ventricular septal defects (VSDs) through illustrative cases. It covers transcatheter closure techniques, zero contrast interventions guided by echocardiography, and innovative approaches to late and residual VSDs following congenital heart surgery.
Challenging clinical scenarios in STEMI
21 May 2026 – From EuroPCR 2026
This session explores challenging clinical scenarios in STEMI, including coronary embolisation from aortic valve vegetation, blunt chest trauma-related STEMI, intramural hematoma diagnostics with multimodality imaging, acute stent thrombosis during dengue recovery, and advanced clot removal techniques beyond standard aspiration devices.
TAVI in heart failure is possible
21 May 2026 – From EuroPCR 2026
This session demonstrates the feasibility of transcatheter aortic valve implantation (TAVI) in patients with heart failure through a series of challenging cases. It covers sequential management of hypertrophic obstructive cardiomyopathy with aortic stenosis, advanced heart failure interventions, staged approaches in cardiogenic shock, and complex percutaneous interventions...
Let's train! How to build a functional training programme for our team?
21 May 2026 – From EuroPCR 2026
This session addresses the common barriers to effective cathlab training and offers a structured approach to building a functional training program tailored to your team's needs. Emphasis is placed on sustainable training models, teamwork, and evaluation methods to ensure competency development and continuous improvement in interventional...
Aortic stenosis: from diagnostic to treatment
21 May 2026 – From EuroPCR 2026
This session provides an in-depth review of contemporary management of aortic stenosis, covering diagnostic advancements, temporal trends, and treatment outcomes. It includes insights from the LAPLACE-TAVI registry focusing on low-risk patients, discusses the growing feasibility of day-case TAVI procedures, compares transcatheter and surgical valve replacements in...
A series of complex real-word challenges STEMI treatment from very different countries
21 May 2026 – From EuroPCR 2026
This session showcases a series of complex STEMI treatment challenges from diverse international settings, highlighting difficult coronary anatomies and complicated procedures. It discusses nuanced clinical scenarios where artery recanalisation does not always equate to reperfusion, and presents stepwise approaches to managing multivessel disease, renal failure, and...
Case-based challenges and dilemmas in multivessel PCI
21 May 2026 – From EuroPCR 2026
This session addresses real-world challenges in multivessel PCI for stable and acute coronary syndromes, emphasizing decision-making, procedure planning, and complication management. It highlights the application of imaging, physiology, and contemporary tools such as DCB to optimize outcomes through illustrative cases from Bangladesh, Brunei Darussalam, and the...
Mitral interventions: procedural risk assessment and interventions
21 May 2026 – From EuroPCR 2026
Focused on mitral valve interventions, this session covers procedural risk assessment and outcomes following transcatheter edge-to-edge repair (TEER). Topics include predictive risk scores, technical complexity, pulmonary artery pressure indices, right ventricle-pulmonary artery coupling, and novel imaging predictors influencing procedural success and patient prognosis.